LL-37 in Thailand: Antimicrobial & Immune Defence Therapy
LL-37 is a naturally occurring host-defence peptide that combines broad-spectrum antimicrobial activity with potent immunomodulatory properties, supporting innate immune defence, wound healing, and inflammatory regulation. In physician-supervised protocols, it is prescribed for immune support, chronic infection management, and mucosal barrier restoration.
Doctor-prescribed LL-37 in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified sourcing. It is prescribed for immune support and antimicrobial protocols, particularly for patients with recurrent infections or compromised innate immune function.
How LL-37 Works
LL-37 operates through multiple sophisticated mechanisms to promote immune defense and tissue repair. Its primary action involves disrupting microbial membranes through direct interaction, providing broad-spectrum antimicrobial activity. The peptide also modulates immune responses by influencing cytokine production and immune cell recruitment. Additionally, LL-37 promotes wound healing through enhanced angiogenesis, cell migration, and re-epithelialization while demonstrating anti-inflammatory properties in specific contexts.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
LL-37
Category
Topical Peptide
Dosage
100-500mcg per application
Frequency
Once or twice daily
Administration
Topical application or subcutaneous injection
Potential Benefits
- · Powerful antimicrobial effects
- · Accelerates wound healing processes
- · Reduces inflammation
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Doctor's Note
Dr. Ploy Pitayanon, MD, Medical Lead
LL-37 requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.
Potential Benefits
Powerful antimicrobial effects
Accelerates wound healing processes
Reduces inflammation
Enhances immune system function
Promotes tissue regeneration
Supports skin barrier function
Shows anti-biofilm activity
Modulates immune responses
Demonstrates anti-cancer potential
Supports respiratory health
Speak with a physician
Interested in LL-37?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
100-500mcg per application
Frequency
Once or twice daily
Duration
4-8 weeks depending on condition
Administration
Topical application or subcutaneous injection
Safety guide
LL-37 Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent LL-37 Research
LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease
Reviewed LL-37's dual roles in innate immunity and tissue repair, demonstrating its antimicrobial activity, immunomodulatory effects, and therapeutic potential in gut inflammation and wound healing (Immun Inflamm Dis, 2026).
View on PubMedExposure to the Antimicrobial Peptide LL-37 Produces Dendritic Cells Optimized for Immunotherapy
Demonstrated LL-37 enhances dendritic cell maturation and antigen presentation, producing immune cells with superior capacity for tumour immunotherapy and anti-cancer immune responses (Oncoimmunology, 2019).
View on PubMedTreatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG in an Ovarian Cancer Model
Showed LL-37 combined with CpG oligodeoxynucleotide significantly enhanced antitumour immune responses in ovarian cancer models, demonstrating its immunostimulatory and anticancer properties (Hum Gene Ther, 2009).
View on PubMedRelated Peptides
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about LL-37